139 related articles for article (PubMed ID: 26598521)
1. Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.
Leong WY; Guo H; Ma O; Huang H; Cantor AB; Friedman AD
J Biol Chem; 2016 Jan; 291(2):826-36. PubMed ID: 26598521
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.
Guo H; Friedman AD
J Biol Chem; 2011 Jan; 286(1):208-15. PubMed ID: 21059642
[TBL] [Abstract][Full Text] [Related]
3. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H; Ma O; Speck NA; Friedman AD
Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
[TBL] [Abstract][Full Text] [Related]
4. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
5. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
7. A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.
Huang H; Woo AJ; Waldon Z; Schindler Y; Moran TB; Zhu HH; Feng GS; Steen H; Cantor AB
Genes Dev; 2012 Jul; 26(14):1587-601. PubMed ID: 22759635
[TBL] [Abstract][Full Text] [Related]
8. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.
Fujimoto T; Anderson K; Jacobsen SE; Nishikawa SI; Nerlov C
EMBO J; 2007 May; 26(9):2361-70. PubMed ID: 17431401
[TBL] [Abstract][Full Text] [Related]
9. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 regulates corepressor interactions of PU.1.
Hu Z; Gu X; Baraoidan K; Ibanez V; Sharma A; Kadkol S; Munker R; Ackerman S; Nucifora G; Saunthararajah Y
Blood; 2011 Jun; 117(24):6498-508. PubMed ID: 21518930
[TBL] [Abstract][Full Text] [Related]
11. The nonreceptor tyrosine kinase c-Abl phosphorylates Runx1 and regulates Runx1-mediated megakaryocyte maturation.
Liu H; Cui Y; Wang GF; Dong Q; Yao Y; Li P; Cao C; Liu X
Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1060-1072. PubMed ID: 29730354
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1.
Wu F; Song T; Yao Y; Song Y
PLoS One; 2019; 14(5):e0216203. PubMed ID: 31048839
[TBL] [Abstract][Full Text] [Related]
13. SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis.
Zhang L; Friedman AD
Blood; 2011 Aug; 118(8):2266-74. PubMed ID: 21725048
[TBL] [Abstract][Full Text] [Related]
14. Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine.
Kato M; Takeda K; Kawamoto Y; Iwashita T; Akhand AA; Senga T; Yamamoto M; Sobue G; Hamaguchi M; Takahashi M; Nakashima I
Cancer Res; 2002 Apr; 62(8):2414-22. PubMed ID: 11956105
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation.
Tachibana M; Tezuka C; Muroi S; Nishimoto S; Katsumoto T; Nakajima A; Kitabayashi I; Taniuchi I
Biochem Biophys Res Commun; 2008 Apr; 368(3):536-42. PubMed ID: 18261462
[TBL] [Abstract][Full Text] [Related]
16. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1.
Yonezawa T; Takahashi H; Shikata S; Liu X; Tamura M; Asada S; Fukushima T; Fukuyama T; Tanaka Y; Sawasaki T; Kitamura T; Goyama S
J Biol Chem; 2017 Jul; 292(30):12528-12541. PubMed ID: 28536267
[TBL] [Abstract][Full Text] [Related]
18. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
19. A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions.
Shiina M; Hamada K; Inoue-Bungo T; Shimamura M; Uchiyama A; Baba S; Sato K; Yamamoto M; Ogata K
J Mol Biol; 2015 Apr; 427(8):1655-69. PubMed ID: 25083921
[TBL] [Abstract][Full Text] [Related]
20. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
